143 related articles for article (PubMed ID: 3812390)
1. Hemagglutination inhibition antibodies in congenital rubella syndrome. A 17-year follow-up in the Ryukyu Islands.
Ueda K; Tokugawa K; Fukushige J; Yoshikawa H; Nonaka S
Am J Dis Child; 1987 Feb; 141(2):211-2. PubMed ID: 3812390
[TBL] [Abstract][Full Text] [Related]
2. Seven-year follow-up study of rubella syndrome in Ryukyu with special reference to persistence of rubella hemagglutination inhibition antibodies.
Ueda K; Nishida Y; Oshima K; Yoshikawa H; Oashi K
Jpn J Microbiol; 1975 Jun; 19(3):181-5. PubMed ID: 1167204
[TBL] [Abstract][Full Text] [Related]
3. Low affinity antibody to rubella antigen in patients after rubella infection in utero.
Fitzgerald MG; Pullen GR; Hosking CS
Pediatrics; 1988 Jun; 81(6):812-4. PubMed ID: 3368279
[TBL] [Abstract][Full Text] [Related]
4. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome.
Mauracher CA; Mitchell LA; Tingle AJ
J Immunol; 1993 Aug; 151(4):2041-9. PubMed ID: 8345195
[TBL] [Abstract][Full Text] [Related]
5. Single-serum diagnosis of rubella by combined use of the hemagglutination inhibition and passive hemagglutination tests.
Inouye S; Satoh K; Tajima T
J Clin Microbiol; 1986 Feb; 23(2):388-91. PubMed ID: 3700622
[TBL] [Abstract][Full Text] [Related]
6. [Rubella HI antibody titer prior to and after the epidemic in the same group and other viral infection in rubella epidemic (author's transl)].
Watanabe N
Kansenshogaku Zasshi; 1979 Mar; 53(3):115-20. PubMed ID: 112196
[No Abstract] [Full Text] [Related]
7. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.
Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M
J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342
[TBL] [Abstract][Full Text] [Related]
8. Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine.
Ushida M; Katow S; Furukawa S
Jpn J Infect Dis; 2003 Apr; 56(2):68-9. PubMed ID: 12824690
[TBL] [Abstract][Full Text] [Related]
9. [Frequency of rubella HI antibody among individuals in Iriomote island in 1970].
Ueda K; Nagayama T; Onishi Y; Yoshikawa H; Oashi K
Kansenshogaku Zasshi; 1973 May; 47(5):144-6. PubMed ID: 4200053
[No Abstract] [Full Text] [Related]
10. [Studies on the management of pregnant women having high hemagglutination inhibition (HI) antibody titer of rubella virus in the first trimester examination of rubella virus antibody in the pregnant women having high HI titer by different methods and prognosis of their infants after birth].
Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1993-9. PubMed ID: 3429981
[TBL] [Abstract][Full Text] [Related]
11. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
12. A novel cell-based high throughput assay to determine neutralizing antibody titers against circulating strains of rubella virus.
Kanbayashi D; Kurata T; Takahashi K; Kase T; Komano J
J Virol Methods; 2018 Feb; 252():86-93. PubMed ID: 29191395
[TBL] [Abstract][Full Text] [Related]
13. Impaired cellular immunity to rubella virus in congenital rubella.
Fuccillo DA; Steele RW; Hensen SA; Vincent MM; Hardy JB; Bellanti JA
Infect Immun; 1974 Jan; 9(1):81-4. PubMed ID: 4808855
[TBL] [Abstract][Full Text] [Related]
14. Assay of rubella antibody by passive hemagglutination and by a modified indirect immunofluorescence test.
Deibel R; D'Arcangelis D; Ducharme CP; Schryver GD
Infection; 1980; 8 Suppl 3():S 255-60. PubMed ID: 6997203
[TBL] [Abstract][Full Text] [Related]
15. Rubella antibody persistence after immunization.
Herrmann KL; Halstead SB; Wiebenga NH
JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a rubella passive hemagglutination test system.
Kilgore JM
J Med Virol; 1979; 3(3):231-6. PubMed ID: 479859
[TBL] [Abstract][Full Text] [Related]
17. Determination of immune status in patients with low antibody titers for rubella virus.
Fayram SL; Akin S; Aarnaes SL; Peterson EM; de la Maza LM
J Clin Microbiol; 1987 Jan; 25(1):178-80. PubMed ID: 3539991
[TBL] [Abstract][Full Text] [Related]
18. Enzygnost-Rubella: an enzyme immunoassay for screening and quantitation of antibodies to rubella virus.
Madsen RD; Witheiler AP; Coates SR; Rippe DF
Am J Clin Pathol; 1983 Feb; 79(2):206-10. PubMed ID: 6337467
[TBL] [Abstract][Full Text] [Related]
19. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
Hoppe G
Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
[TBL] [Abstract][Full Text] [Related]
20. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
Grillner L
J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
